Asymmetric synthesis

Asymmetric synthesis

Asymmetric synthesis, also called chiral synthesis, enantioselective synthesis or stereoselective synthesis, is organic synthesis which introduces one or more new and desired elements of chirality. [GoldBookRef|title=asymmetric synthesis| file = A00484] [GoldBookRef|title=stereoselective synthesis|file = S05990] This is important in the field of pharmaceuticals because the different enantiomers or diastereomers of a molecule often have different biological activity.


There are three main approaches to asymmetric synthesis:
* chiral pool synthesis
* chiral auxiliaries
* asymmetric catalysis

In practice, a mixture of all three is often used in order to maximize the advantages of each method.

Chirality must be introduced to the substance first. Then, it must be maintained. Care needs to be taken when planning the synthesis: the chirality might be removed by a chemical change that makes the substance isotropic. This process is called epimerization. For example, a SN1 substitution reaction converts a molecule that is chiral by merit of non-planarity into a planar molecule, which has no handedness. (To visualise, draw the outlines of both of your hands on paper, and cut the images out. You can now superimpose the images, even if the hands themselves do not superimpose.) In a SN2 substitution reaction on the other hand the chirality inverts, i.e. when you start with a right-handed mixture, you'll end up with left-handed one. (A visualization could be inverting an umbrella. The mechanism looks just the same.)

Chiral pool synthesis

Chiral pool synthesis is the easiest approach: a chiral starting material is manipulated through successive reactions using achiral reagents which retain its chirality to obtain the desired target molecule. This is especially attractive for target molecules having the similar chirality to a relatively inexpensive naturally occurring building block such as a sugar or amino acid. However, the number of possible reactions the molecule can undergo are restricted, and tortuous synthetic routes may be required. Also, this approach requires a stoichiometric amount of the enantiopure starting material, which may be rather expensive if not occurring in nature, whereas chiral catalysis requires only a catalytic amount of chiral material.

Asymmetric induction

What many strategies in chiral synthesis have in common is asymmetric induction. The aim is to make enantiomers into diastereomers, since diastereomers have different reactivity, but enantiomers do not. To make enantiomers into diastereomers, the reagents or the catalyst need to be incorporated with an enantiopure chiral center. The reaction will now proceed differently for different enantiomers, because the transition state of the reaction can exist in two diastereomers with respect to the enantiopure center, and these diastereomers react differently.

Asymmetric induction can also occur intramolecularly when given a chiral starting material. This chirality transfer can be exploited, especially when the goal is to make several consecutive chiral centers to give a specific enantiomer of a specific diastereomer. An aldol reaction, for example, is inherently diastereoselective; if the aldehyde is enantiopure, the resulting aldol adduct is diastereomerically and enantiomerically pure.

Chiral auxiliary

One asymmetric induction strategy is the use of a chiral auxiliary which forms an adduct to the starting materials and physically blocks the other trajectory for attack, leaving only the desired trajectory open. Assuming the chiral auxiliary is enantiopure, the different trajectories are not equivalent, but diastereomeric. The auxiliary shares problems similar to protecting groups; like protecting groups, auxiliaries require a reaction step to add and another to remove, increasing cost and decreasing yield.

The oldest asymmetric synthesis is the enantioselective decarboxylation of the malonic acid "2-ethyl-2-methylmalonic acid" mediated by brucine (forming the salt) as reported by Willy Marckwald in 1904: [cite journal | doi = 10.1002/cber.19040370165 | title = Ueber asymmetrische Synthese | year = 1904 | author = Marckwald, W. | journal = Berichte der deutschen chemischen Gesellschaft | volume = 37 | pages = 349] [cite journal | doi = 10.1002/cber.19040370226 | title = Ueber asymmetrische Synthese | year = 1904 | author = Marckwald, W. | journal = Berichte der deutschen chemischen Gesellschaft | volume = 37 | pages = 1368]


Asymmetric catalysis

Small amounts of chiral, enantiomerically pure (or enriched) catalysts promote reactions and lead to the formation of large amounts of enantiomerically pure or enriched products. [a) Comprehensive Asymmetric Catalysis (Jacobsen, Pfaltz, Yamamoto), Springer, 1999; b) Catalytic Asymmetric Synthesis, (Ojima), Wiley, 2000.] [cite journal | author = M. Heitbaum, F. Glorius and I. Escher | title = Asymmetric Heterogeneous Catalysis | year = 2006 | journal = Angewandte Chemie International Edition | volume = 45 | issue = 29 | pages = 4732–4762 | doi = 10.1002/anie.200504212] [Asymmetric Catalysis on Industrial Scale, (Blaser, Schmidt), Wiley-VCH, 2004.] Mostly, three different kinds of chiral catalysts are employed:
# metal ligand complexes derived from chiral ligands
# chiral organocatalysts and
# biocatalysts.The first methods were pioneered by William S. Knowles and Ryoji Noyori (Nobel Prize in Chemistry 2001). Knowles in 1968 [Nobel prize 2001 [ Link] ] replaced the achiral triphenylphosphine ligands in Wilkinson's catalyst by the chiral phosphine ligands P(Ph)(Me)(Propyl) thus creating the first asymmetric catalyst. This experimental catalyst was employed in an asymmetric hydrogenation with a modest 15% enantiomeric excess result. The methodology was ultimately used by him (while working for the Monsanto company) in an asymmetric hydrogenation step in the industrial production of L-DOPA:


In the same year and independently Noyori [cite journal | title = Homogeneous catalysis in the decomposition of diazo compounds by copper chelates: Asymmetric carbenoid reactions | journal = Tetrahedron | volume = 24 | issue = 9 | year = 1968 | pages = 3655–3669 | author = H. Nozaki, H. Takaya, S. Moriuti, R. Noyori | doi = 10.1016/S0040-4020(01)91998-2] published his chiral ligand for a cyclopropanation reaction of styrene. In common with Knowles the enantiomeric excess for this first generation ligand was disappointingly low: 6%.


Examples of asymmetric catalysis include:
* BINAP, a chiral phosphine, used in combination with compounds of ruthenium or rhodium. These complexes catalyse the hydrogenation of functionalised alkenes well on only one face of the molecule. This process also developed by Ryoji Noyori is commercialized as the industrial synthesis of menthol using a chiral BINAP-rhodium complex.
* The other part of that Nobel prize concerned the Sharpless bishydroxylation
* Naproxen is synthesized with a chiral phosphine ligand in a Hydrocyanation reaction
* asymmetric catalytic reduction and oxidation

Biocatalysis & organocatalysis

Biocatalysis makes use of enzymes to effect chemical reagents stereoselectively. Some small organic molecules can also be used to help accelerate the desired reaction; this method is known as organocatalysis. If the organic molecule is chiral, it may react preferentially with the substrate of a certain chirality.


Apart from asymmetric synthesis, racemic mixtures of compounds may be separated by various techniques in chiral resolution. Where the cost in time and money of making such racemic mixtures is low, or if both enantiomers may find use, this approach may remain cost-effective.

ee also

* Aza-Baylis-Hillman reaction, for the use of a chiral ionic liquid in asymmetric synthesis.


Wikimedia Foundation. 2010.

Look at other dictionaries:

  • asymmetric synthesis — Chemical reaction by which unequal amounts of two product isomers are formed. It is normally not possible to synthesize from materials that do not have optical activity (i.e., are not chiral) one stereoisomer of a chiral compound without the… …   Universalium

  • asymmetric synthesis — asimetrinė sintezė statusas T sritis chemija apibrėžtis Sintezė, kurios metu susidaro nevienodas kiekis stereoizomerų, turinčių naują chiralinį centrą. atitikmenys: angl. asymmetric synthesis rus. асимметрический синтез …   Chemijos terminų aiškinamasis žodynas

  • asymmetric synthesis — noun chemistry : a process that directly produces an optically active compound (as one containing an asymmetric carbon atom) from symmetrically constituted molecules without requiring resolution of a racemic mixture …   Useful english dictionary

  • asymmetric synthesis — noun The synthesis of a specific enantiomer of a compound (or of a mixture containing more of one enantioner than the other) …   Wiktionary

  • Asymmetric induction — (also enantioinduction) in stereochemistry describes the preferential formation in a chemical reaction of one enantiomer or diastereoisomer over the other as a result of the influence of a chiral feature present in the substrate, reagent,… …   Wikipedia

  • Asymmetric dimethylarginine — IUPAC name (2S) 2 Amino 5 [(amino dimethylaminomethylene)amino]pentanoic acid …   Wikipedia

  • Asymmetric catalytic reduction — is the use of various chiral catalysts to reduce a prochiral organic compound to obtain a chiral product. This is one of the several techniques used in chiral synthesis.Typically, a transition metal is used with a bulky chiral ligand to such that …   Wikipedia

  • Enantioselective synthesis — Enantioselective synthesis: Sharpless epoxidation Enantioselective synthesis, also called chiral synthesis, asymmetric synthesis or stereoselective synthesis, is organic synthesis that introduces one or more new and desired elements of… …   Wikipedia

  • Organic synthesis — This article is about artificial synthesis of organic compounds. For the journal Organic Syntheses, see Organic Syntheses. For synthesis in organisms, see Biosynthesis. Organic synthesis is a special branch of chemical synthesis and is concerned… …   Wikipedia

  • Oseltamivir total synthesis — concerns the total synthesis of the antiinfluenza drug oseltamivir marketed by Hoffmann La Roche under the trade name Tamiflu. Its commercial production starts from the biomolecule shikimic acid harvested from Chinese star anise with a limited… …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”

We are using cookies for the best presentation of our site. Continuing to use this site, you agree with this.